Your fact-checks will appear here
Family name
Multiple news organizations and fact‑checkers dissected President Trump’s Dec. 17, 2025 televised address, focusing on economic and immigration claims; the checks repeatedly found his most specific nu...
Public opinion polls from late 2024–early 2025 show large shares of Americans saying Joe Biden will be judged poorly by history: Gallup found 54% expect him to be “below average” or “poor” (a net scor...
National polling through early January 2026 shows Donald Trump running below majority approval in most large trackers, with averages and reputable polls clustering in the high-30s to low‑40s for “appr...
Available reporting shows common COVID-19 vaccine reactions are short-lived (sore arm, fever, fatigue that usually resolve in 1–2 days) and that serious, long-term adverse events linked to vaccines ha...
Polls taken in early to mid‑November 2025 show President Donald Trump’s approval clustered in the high‑30s to low‑40s, with several major trackers reporting around 37–42% approval and disapproval gene...
’s approval rating sits in the low-to-mid 40s across major national poll aggregates, with averaging roughly 42–46 percent depending on the window used (RealClear) . Polls show entrenched partisan supp...
Donald Trump’s approval during his second term has generally trended in the high‑30s to low‑40s across major trackers, hitting Gallup lows near 36–37% and aggregate measures near the low‑40s, while re...
Most reporting and public-health guidance in the provided sources say mRNA COVID-19 vaccine side effects are usually short-lived and mostly mild — commonly a sore arm, fatigue, headache and muscle ach...
In December 2025, national "right track/wrong track" questions trended toward "wrong track" in most mainstream, large‑sample polls but showed higher "right track" readings in at least one long‑running...
Multiple follow‑up polls after the Hunter Biden laptop revelations suggested some voters said they would have changed their 2020 vote had they known the laptop was genuine: surveys or summaries cited ...
CNN’s recent polling cycle shows President Trump’s approval in the high 30s, with a CNN/SSRS headline figure of that CNN characterized as the lowest of his second term . Rasmussen’s nightly tracking h...
In October 2025, available public polling in the provided dataset does not establish a clear, single national approval rating for Vice President Kamala Harris; the most directly cited national measure...
Fact‑checkers and media watchdogs converged on the core facts: Scott Adams used a Rasmussen poll about the phrase “It’s OK to be white” as the springboard for a February 2023 YouTube livestream in whi...
No single authoritative percentage exists in the cited reporting that quantifies “what percentage of U.S. political violence incidents by 2025 were linked to online radicalization or fringe social net...
Available reporting and guidance show that younger adults tend to report more and stronger short-term reactions to Pfizer’s COVID-19 vaccines than older adults, while serious adverse events (like conf...
Government shutdowns shift public blame and depress congressional ratings but produce mixed effects on presidential approval, with recent 2025–2026 polling showing : some national trackers show Presid...
The 34 felony charges and subsequent conviction against Donald Trump have uncertain effects: legal experts say a felony does not bar someone from running for or serving as president , yet a May 2024 j...
Donald Trump’s approval was unusually stable and polarized through crises: he averaged about 41% in his first term and hit highs near 49% around the first Senate impeachment and early COVID-19 period,...
Available reporting emphasizes that COVID-19 vaccination reduces risk of severe illness, hospitalization and likely reduces risk of long COVID by preventing infection, while most documented vaccine re...
Clinical and public reporting in the provided sources emphasize that most COVID-19 vaccine reactions are short‑lived local or systemic symptoms (sore arm, fever, fatigue) and that serious adverse even...